Allogene Therapeutics, Inc.
NASDAQ:ALLO
1.89 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0.095 | 0.243 | 38.489 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 242.914 | 16.728 | 13.065 | 11.541 | 5.027 | 1.5 | 0 |
| Brutowinst
| 0 | -242.819 | -16.485 | 25.424 | -11.541 | -5.027 | -1.5 | 0 |
| Brutowinstmarge
| 0 | -2,555.989 | -67.84 | 0.661 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 192.299 | 242.914 | 256.387 | 220.176 | 192.987 | 144.535 | 151.86 | 0 |
| Algemene en administratieve kosten
| 65.205 | 71.673 | 79.305 | 74.105 | 65.256 | 57.473 | 40.982 | 0.024 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.022 |
| Verkoop-, algemene en administratieve kosten
| 65.205 | 71.673 | 79.305 | 74.105 | 65.256 | 57.473 | 40.982 | 0.002 |
| Overige kosten
| 15.717 | 13.245 | -1.749 | -2.927 | -1.142 | -0.268 | -21.211 | 0 |
| Bedrijfskosten
| 273.221 | 327.832 | 335.692 | 294.281 | 258.243 | 202.008 | 192.842 | 0.002 |
| Bedrijfsresultaat
| -273.199 | -327.737 | -335.449 | -255.792 | -258.243 | -202.008 | -192.842 | -0.002 |
| Bedrijfsresultaat ratio
| 0 | -3,449.863 | -1,380.449 | -6.646 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 16.052 | 0.472 | -4.878 | -1.859 | 8.022 | 17.083 | -18.78 | -0.022 |
| Inkomen voor belasting
| -257.147 | -327.265 | -332.632 | -257.005 | -250.221 | -184.925 | -211.622 | -0.002 |
| Inkomen voor belasting ratio
| 0 | -3,444.895 | -1,368.856 | -6.677 | 0 | 0 | 0 | 0 |
| Belastingkosten
| -0.443 | 0 | -2.817 | -12.168 | -16.75 | -0.331 | -0.117 | -0.024 |
| Nettowinst
| -257.59 | -327.265 | -329.815 | -244.837 | -233.471 | -184.594 | -211.505 | -0.002 |
| Nettowinstmarge
| 0 | -3,444.895 | -1,357.263 | -6.361 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -1.32 | -2.09 | -2.3 | -1.8 | -1.94 | -1.83 | -7.31 | 0 |
| Verwaterde WPA
| -1.32 | -2.09 | -2.3 | -1.8 | -1.94 | -1.83 | -7.31 | 0 |
| EBITDA
| -273.199 | -300.293 | -321.241 | -169.738 | -250.808 | -179.898 | -206.764 | 0.022 |
| EBITDA ratio
| 0 | -3,160.979 | -1,380.449 | -6.646 | 0 | 0 | 0 | 0 |